Skip to content
Peptigraph home

Why does tesamorelin burn?

The label lists injection site reactions, including pain, irritation and erythema, which affected 25% of treated patients versus 14% on placebo in the first 26 weeks.

GHRH analogUpdated

Short answer

The label lists injection site reactions, including pain, irritation and erythema, which affected 25% of treated patients versus 14% on placebo in the first 26 weeks.[1]

What the label lists

The label names the reactions as erythema, pruritus, pain, irritation and bruising.[1]

Injection site erythema and pruritus are among the most commonly reported adverse reactions.[1]

The label separately lists hypersensitivity reactions as a warning and says to stop treatment if one is suspected.[1]

More on Tesamorelin

Sources

  1. 1EGRIFTA SV prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.